Irs2 Phenotype Annotations - Multigenic Genotypes

Mammalian Phenotype Ontology Annotations
Query Results - Summary

Symbol
Name
ID

Irs2
insulin receptor substrate 2
MGI:109334

45 phenotypes from multigenic genotypes

Allelic Composition Genetic Background	Annotated Term	Reference
Cdkn1b^tm1Kin/Cdkn1b⁺ Irs2^tm1Mfw/Irs2^tm1Mfw involves: 129S1/Sv * 129X1/SvJ * C57BL/6J	enlarged pancreatic islets	J:96047
	increased circulating glucose level	J:96047
	increased circulating insulin level	J:96047
	increased pancreatic beta cell number	J:96047
Cdkn1b^tm1Kin/Cdkn1b^tm1Kin Irs2^tm1Mfw/Irs2^tm1Mfw involves: 129S1/Sv * 129X1/SvJ * C57BL/6J	enlarged pancreatic islets	J:96047
	increased circulating glucose level	J:96047
	increased circulating insulin level	J:96047
	increased pancreatic beta cell number	J:96047
Foxo1^tm1Rdp/Foxo1^tm1Rdp Irs1^tm1Mfw/Irs1^tm1Mfw Irs2^tm2Mfw/Irs2^tm2Mfw Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA * FVB	abnormal triglyceride level	J:137845
	decreased circulating cholesterol level	J:137845
	decreased circulating free fatty acids level	J:137845
	decreased circulating HDL cholesterol level	J:137845
	decreased circulating triglyceride level	J:137845
	normal homeostasis/metabolism phenotype	J:137845
Foxo1^tm1Whb/Foxo1⁺ Irs2^tm1Mfw/Irs2^tm1Mfw involves: 129S1/Sv * 129X1/SvJ * C57BL/6	normal endocrine/exocrine gland phenotype	J:80826
	normal homeostasis/metabolism phenotype	J:80826
Gsk3b^tm1Jrw/Gsk3b⁺ Irs2^tm1Mfw/Irs2^tm1Mfw involves: 129S1/Sv * 129X1/SvJ * C57BL/6J	abnormal circulating glucose level	J:135659
	abnormal pancreatic islet cell apoptosis	J:135659
	normal growth/size/body region phenotype	J:135659
	increased circulating glucose level	J:135659
	increased circulating insulin level	J:135659
	increased pancreatic beta cell proliferation	J:135659
	insulin resistance	J:135659
Gsk3b^tm2Jrw/Gsk3b^tm2Jrw Irs2^tm1Mfw/Irs2^tm1Mfw Tg(Ins2-cre)23Herr/? involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J	abnormal circulating glucose level	J:135659
	increased circulating insulin level	J:135659
Insr^tm1Dac/Insr⁺ Irs2^tm1Mfw/Irs2^tm1Mfw involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6	abnormal glucose homeostasis	J:80826
	absent pancreatic beta cells	J:80826
	postnatal lethality	J:80826
Irs1^tm1Jos/Irs1⁺ Irs2^tm2Mfw/Irs2^tm2Mfw Tg(Ins2-cre)25Mgn/0 involves: 129S1/Sv * 129X1/SvJ * C57BL/6	abnormal pancreatic beta cell morphology	J:93415
	decreased body weight	J:93415
	decreased circulating insulin level	J:93415
	hyperglycemia	J:93415
Irs1^tm1Mfw/Irs1⁺ Irs2^tm2Mfw/Irs2^tm2Mfw Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA * FVB/N	impaired glucose tolerance	J:156999
Irs1^tm1Mfw/Irs1^tm1Mfw Irs2^tm2Mfw/Irs2^tm2Mfw Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA	abnormal triglyceride level	J:137845
	decreased body size	J:137845
	decreased circulating cholesterol level	J:137845
	decreased circulating free fatty acids level	J:137845
	decreased circulating HDL cholesterol level	J:137845
	decreased circulating triglyceride level	J:137845
	decreased liver glycogen level	J:137845
	hyperglycemia	J:137845
	impaired glucose tolerance	J:137845
	increased circulating glucose level	J:137845
	increased circulating insulin level	J:137845
	increased susceptibility to autoimmune diabetes	J:137845
	insulin resistance	J:137845
Irs1^tm1Mfw/Irs1^tm2.1Mfw Irs2^tm2Mfw/Irs2^tm2Mfw Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA * FVB/N	impaired glucose tolerance	J:156999
	increased circulating insulin level	J:156999
	insulin resistance	J:156999
Irs1^tm1Tka/Irs1^tm1Tka Irs2^tm1Tka/Irs2^tm1Tka involves: C57BL/6 * CBA	abnormal cell differentiation	J:68004
	decreased white adipose tissue amount	J:68004
Irs1^tm2.1Mfw/Irs1^tm2.1Mfw Irs2^tm2Mfw/Irs2^tm2Mfw Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA * FVB/N	impaired glucose tolerance	J:156999
	increased circulating insulin level	J:156999
Irs1^tm2Tka/Irs1^tm2Tka Irs2^tm2Tka/Irs2^tm2Tka Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA	increased susceptibility to autoimmune diabetes	J:137846
	insulin resistance	J:137846
Irs2^tm1Mfw/Irs2^tm1Mfw Ptpn1^tm1Bbk/Ptpn1^tm1Bbk involves: 129S1/Sv * 129X1/SvJ * C57BL/6	abnormal pancreatic beta cell morphology	J:87249
	decreased body weight	J:87249
	hyperglycemia	J:87249
	impaired glucose tolerance	J:87249
	increased insulin sensitivity	J:87249
	pancreatic islet hyperplasia	J:87249
	premature death	J:87249
Irs2^tm1Mfw/Irs2^tm1Mfw Tg(Pdx1)#Mmy/0 involves: 129S1/Sv * 129X1/SvJ * C57BL/6	abnormal retina layer morphology	J:98107
	decreased total retina thickness	J:98107
	retina outer nuclear layer degeneration	J:98107
	retina photoreceptor degeneration	J:98107
Irs2^tm2Mfw/Irs2^tm2Mfw Irs4^tm1.1Mfw/Y Lepr^tm3(cre)Mgmj/Lepr⁺ involves: 129S1/Sv * 129X1/SvJ * C57BL/6	normal growth/size/body region phenotype	J:221293
	normal homeostasis/metabolism phenotype	J:221293
Irs2^tm2Mfw/Irs2^tm2Mfw Irs4^tm1.1Mfw/Y Tg(Nes-cre)1Kln/? involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL	abnormal adipose tissue amount	J:221293
	abnormal glucose homeostasis	J:221293
	decreased basal metabolism	J:221293
	decreased oxygen consumption	J:221293
	hepatic steatosis	J:221293
	impaired glucose tolerance	J:221293
	increased body weight	J:221293
	increased brown fat cell lipid droplet size	J:221293
	increased circulating glucose level	J:221293
	increased circulating insulin level	J:221293
	increased circulating leptin level	J:221293
	increased fasting circulating glucose level	J:221293
	increased food intake	J:221293
	insulin resistance	J:221293

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 11/12/2024 MGI 6.24